Bevacizumab/iodine-125/triamcinoloneRadiation retinopathy and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1915卷 / 1期

关键词：

D O I：

10.1007/s40278-022-19130-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：101 / 101

相关论文

共 50 条

[21] Iodine-131Lack of efficacy: case report
Reactions Weekly, 2023, 1960 (1) : 245 - 245
[22] Iodine-131Lack of efficacy: case report
Reactions Weekly, 2021, 1847 (1) : 255 - 255
[23] Iodine-131Lack of efficacy: case report
Reactions Weekly, 2022, 1906 (1) : 229 - 229
[24] Iodine-131Lack of efficacy: case report
Reactions Weekly, 2024, 2034 (1) : 181 - 181
[25] Iodine-131Lack of efficacy: case report
Reactions Weekly, 2023, 1975 (1) : 197 - 197
[26] Iodine-131Lack of efficacy: case report
Reactions Weekly, 2023, 1948 (1) : 243 - 243
[27] Atezolizumab/bevacizumab/sorafenibVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2023, 1976 (1) : 59 - 59
[28] Bevacizumab/triamcinoloneCentral serous chorioretinopathy and lack of efficacy: case report
Reactions Weekly, 2022, 1920 (1) : 111 - 111
[29] Bevacizumab/Eribulin/PaclitaxelAcute pancreatitis and lack of efficacy: case report
Reactions Weekly, 2024, 2035 (1) : 112 - 112
[30] Bevacizumab/triamcinoloneUveitis, sterile endophthalmitis and lack of efficacy: case report
Reactions Weekly, 2020, 1832 (1) : 78 - 78

← 1 2 3 4 5 →